Browse Categories
Browse by Date
- 2020
- August
- July
- June
- May
- April
- March
- February
- January
- 2019
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2018
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2017
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2016
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2015
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2014
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2013
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2012
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
Report: Interoperability does not affect EHR buying decision
Healthcare research firm KLAS reports that healthcare providers remain strongly concerned about interoperability of technology from various vendors and "strongly encourage better coordination among vendors, timely location of patient records and greatly improved parsing...
The Food and Drug Administration has approved an advanced treatment for mantle cell lymphoma, a rare type of cancer affecting white blood cells. The one-time therapy, made by Gilead Sciences, is branded as Tecartus. This is the third federal approval of a CAR-T therapy,...
On July 24, the U.S. Food and Drug Administration approved Tecartus, a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell lymphoma who have not responded to or who have relapsed following other kinds of treatment.
The study, published in Cell Stem Cell, also sheds light on how aging can cause lung regeneration to go awry, which can lead to lung cancer and other diseases. “There currently are few therapies that target the biology of lung diseases,” said Dr. Brigitte...
The self-eating process in embryonic stem cells known as chaperone-mediated autophagy and a related metabolite may serve as promising new therapeutic targets to repair or regenerate damaged cells and organs, Penn Medicine researchers...
Reports show that cancer is the second leading cause of death globally. Scientists from Duke-NUS Medical School have found DNA mutations in some cancers that link them to a bacterial toxin called colibactin. Their findings, published in the journals Gastroenterology and...
The US Food and Drug Administration has given the go-ahead to allow an existing COVID-19 diagnostic test be indicated for everyone. On July 24, the FDA reissued LabCorp’s COVID-19 RT-PCR Test for emergency use authorization to indicate it for use to test people who...
RECOMMENDED:
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
